Asthma diagnosis and long-term management UK Medical PG Practice Questions and MCQs
Practice UK Medical PG questions for Asthma diagnosis and long-term management. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Asthma diagnosis and long-term management UK Medical PG Question 1: A 56-year-old man presents with progressive dyspnea and chest tightness. He works in coal mining. Chest X-ray shows bilateral upper lobe nodules. What is the most likely diagnosis?
- A. Lung cancer
- B. Silicosis
- C. Coal worker's pneumoconiosis (Correct Answer)
- D. Tuberculosis
- E. Sarcoidosis
Asthma diagnosis and long-term management Explanation: ***Coal worker's pneumoconiosis***- This diagnosis is strongly supported by the patient's occupational exposure to **coal dust** and the progressive respiratory symptoms like **dyspnea** and **chest tightness**.- The characteristic Chest X-ray finding of bilateral, often small, **pulmonary nodules** predominantly located in the **upper lung zones** is classic for this condition.*Lung cancer*- Although coal miners have an increased risk of lung cancer, the presentation of diffuse **bilateral small nodules** is more typical of a pneumoconiosis than primary malignancy.- Lung cancer usually manifests as a single, dominant mass, or less commonly as reticulonodular interstitial disease, not typically as diffuse, symmetrical small nodules.*Silicosis*- Silicosis is caused by the inhalation of **crystalline silica** dust, prevalent in occupations like sandblasting or quarrying, which differs from pure coal mining exposure.- While silicosis also causes upper lobe nodules, it often presents radiologically with **"eggshell" calcification** of the hilar lymph nodes, a finding not specified in this case.*Tuberculosis*- Although **post-primary TB** targets the upper lobes, generalized diffuse nodularity suggests pneumoconiosis rather than a primary mycobacterial infection.- TB typically presents with systemic symptoms like **fever**, **night sweats**, and **weight loss**, which are not mentioned in this patient's presentation.*Sarcoidosis*- Sarcoidosis is a systemic disease of unknown etiology characterized by **non-caseating granulomas** and classically presents with **bilateral hilar lymphadenopathy (BHL)** on chest imaging.- The strong history of **coal mining** is the key factor favoring an occupational lung disease over sarcoidosis, as BHL is also absent.
Asthma diagnosis and long-term management UK Medical PG Question 2: A 56-year-old man presents with progressive dyspnea and dry cough. HRCT shows bilateral lower lobe fibrosis with honeycombing. He has clubbing and restrictive spirometry. What medication may slow disease progression?
- A. Prednisolone
- B. Azathioprine
- C. Pirfenidone (Correct Answer)
- D. Cyclophosphamide
- E. N-acetylcysteine
Asthma diagnosis and long-term management Explanation: ***Pirfenidone***- The clinical presentation with progressive dyspnea, dry cough, clubbing, restrictive spirometry, and HRCT showing bilateral lower lobe fibrosis with **honeycombing** is highly characteristic of **Idiopathic Pulmonary Fibrosis (IPF)**.- **Pirfenidone** is an **anti-fibrotic** agent, along with nintedanib, approved for the treatment of mild to moderate IPF to slow disease progression by reducing the decline in **Forced Vital Capacity (FVC)**.*Prednisolone*- Systemic corticosteroids like **Prednisolone** are not recommended as monotherapy for **Idiopathic Pulmonary Fibrosis (IPF)** due to lack of proven long-term efficacy and potential harm.- They are primarily indicated for inflammatory interstitial lung diseases, such as those associated with **connective tissue diseases**, or for **acute exacerbations** of IPF.*Azathioprine*- **Azathioprine** is an immunosuppressant that was shown to be ineffective and potentially harmful in a triple-drug regimen for IPF in the **PANTHER-IPF trial**.- Immunosuppression is generally avoided in **Idiopathic Pulmonary Fibrosis** unless there is a strong suspicion of an alternative, inflammatory interstitial lung disease.*Cyclophosphamide*- **Cyclophosphamide** is a potent cytotoxic immunosuppressant typically reserved for severe, rapidly progressive forms of **connective tissue disease-associated ILD** (e.g., scleroderma-associated ILD or vasculitis).- It is not indicated for the primary management of **Idiopathic Pulmonary Fibrosis**, which is characterized by relentless fibrosis rather than a primary inflammatory process responsive to this therapy.*N-acetylcysteine*- Although previously studied for its antioxidant properties, the **PANTHER-IPF trial** demonstrated that **N-acetylcysteine** offered no benefit in slowing the progression of IPF and is no longer recommended.- Its primary clinical uses are as a mucolytic agent and as an antidote for **acetaminophen overdose**.
Asthma diagnosis and long-term management UK Medical PG Question 3: A 54-year-old man presents with progressive dyspnea and chest tightness. Spirometry shows FEV1 1.8L (60% predicted), FEV1/FVC 0.55. He has a 40 pack-year smoking history. What is the most important intervention?
- A. Bronchodilators
- B. Inhaled corticosteroids
- C. Smoking cessation (Correct Answer)
- D. Pulmonary rehabilitation
- E. Long-term oxygen therapy
Asthma diagnosis and long-term management Explanation: ***Smoking cessation***- This is the **single most important intervention** for patients with **COPD** who smoke, as it is the only measure proven to slow the rate of **FEV1 decline** and disease progression.- Quitting smoking significantly reduces symptoms, exacerbations, and mortality, directly addressing the primary etiological factor in this patient's 40 pack-year history.*Bronchodilators*- **Bronchodilators** (e.g., beta-agonists, anticholinergics) provide crucial **symptomatic relief** by improving airflow and reducing dyspnea, but they do not alter the natural history of COPD or stop the underlying disease progression.- They are essential for managing symptoms but are not the **most important intervention** to halt the destruction caused by smoking.*Inhaled corticosteroids*- **Inhaled corticosteroids (ICS)** are typically indicated for patients with more severe COPD (e.g., FEV1 < 50% predicted) and a history of **frequent exacerbations**, often in combination with long-acting bronchodilators.- While they can reduce inflammation and exacerbation rates, ICS do not reverse or prevent the progressive lung damage caused by smoking.*Pulmonary rehabilitation*- **Pulmonary rehabilitation** is a highly effective intervention that improves **exercise capacity**, reduces dyspnea, and enhances quality of life in patients with COPD.- However, it does not modify the underlying **disease progression** or stop the decline in lung function, which is the primary benefit of smoking cessation.*Long-term oxygen therapy*- **Long-term oxygen therapy (LTOT)** is indicated for patients with **severe chronic hypoxemia** (PaO2 < 55 mmHg or SaO2 < 88%) to improve survival and quality of life.- This intervention addresses a consequence of advanced COPD but does not directly prevent or slow the progression of the disease itself, which is the focus of the question.
Asthma diagnosis and long-term management UK Medical PG Question 4: A 58-year-old man presents with progressive dyspnea and fatigue. Chest X-ray shows bilateral lower lobe shadowing. HRCT shows honeycombing and traction bronchiectasis. He has finger clubbing. What is the prognosis?
- A. Excellent with treatment
- B. Good with early intervention
- C. Variable depending on cause
- D. Poor with median survival 2-5 years (Correct Answer)
- E. Benign condition
Asthma diagnosis and long-term management Explanation: ***Poor with median survival 2-5 years***- The progressive dyspnea, fatigue, finger clubbing, and HRCT findings of **honeycombing** and **traction bronchiectasis** are classic features of **Idiopathic Pulmonary Fibrosis (IPF)**.- IPF is a relentlessly progressive lung disease with a **poor prognosis**, typically having a median survival of **2 to 5 years** from diagnosis without lung transplantation.*Excellent with treatment*- IPF is an **irreversible, progressive fibrotic lung disease** for which there is currently no curative medical treatment, precluding an excellent prognosis.- Although anti-fibrotic medications can slow the rate of decline, they do not halt or reverse the underlying **pulmonary fibrosis**.*Good with early intervention*- Despite early diagnosis and intervention with anti-fibrotic drugs, the established **Usual Interstitial Pneumonia (UIP)** pattern of IPF implies a rapid and unfavorable progression.- Patients with IPF remain at high risk of **acute exacerbations** and progressive **respiratory failure**, even with timely management.*Variable depending on cause*- The classic presentation of progressive dyspnea, clubbing, and a definable **UIP pattern** on HRCT points strongly to **Idiopathic Pulmonary Fibrosis**, which has a consistently unfavorable prognosis.- Prognostic variability is more often associated with other Interstitial Lung Diseases (ILDs) like non-specific interstitial pneumonia (**NSIP**), not IPF.*Benign condition*- IPF is far from benign; it is a serious, ultimately **fatal condition** characterized by continuous and irreversible destruction of lung architecture.- The presence of **traction bronchiectasis** and **honeycombing** signifies advanced, non-reversible scarring and distortion of lung tissue, indicating a severe disease.
Asthma diagnosis and long-term management UK Medical PG Question 5: A 55-year-old man presents with progressive dyspnea and dry cough over 6 months. He has finger clubbing. HRCT shows honeycombing and reticular opacities in lower lobes. What is the most likely diagnosis?
- A. COPD
- B. Asthma
- C. Idiopathic pulmonary fibrosis (Correct Answer)
- D. Hypersensitivity pneumonitis
- E. Sarcoidosis
Asthma diagnosis and long-term management Explanation: ***Idiopathic pulmonary fibrosis***
- The combination of progressive dyspnea, dry cough, and **finger clubbing** in an older patient strongly suggests a chronic fibrotic lung process.
- HRCT findings of **honeycombing** and **reticular opacities** primarily in the lower lobes are pathognomonic for the Usual Interstitial Pneumonia (**UIP**) pattern, which defines Idiopathic Pulmonary Fibrosis (IPF).
*COPD*
- COPD is an **obstructive lung disease** and typically presents with chronic productive cough and sputum, often related to smoking.
- HRCT features usually involve **emphysema** (air space enlargement) or bronchial wall thickening, not severe lower lobe fibrosis with honeycombing.
*Asthma*
- Asthma is characterized by **reversible airway obstruction** and episodic wheezing, often triggered by specific exposures.
- HRCT is usually normal or shows mild signs of **air trapping**, and **clubbing** is not a feature of asthma.
*Hypersensitivity pneumonitis*
- Acute or subacute forms often show **centrilobular nodules** or ground-glass opacities, often with a documented environmental exposure history.
- While chronic HP can cause fibrosis, the pattern is often different from UIP, frequently involving the **upper or mid-lung zones** and sparing the bases.
*Sarcoidosis*
- Sarcoidosis is classically associated with **hilar lymphadenopathy** and primarily affects the **upper and mid-lung zones**, showing peribronchovascular nodularity.
- **Clubbing** is very rare, and the typical HRCT pattern is **perilymphatic**, unlike the peripheral subpleural pattern seen here.
Asthma diagnosis and long-term management UK Medical PG Question 6: A 48-year-old man presents with progressive breathlessness and fatigue. Chest X-ray showed bilateral hilar lymphadenopathy. Serum ACE is elevated. Transbronchial biopsy shows no caseating granulomas. What is the most likely diagnosis?
- A. Tuberculosis
- B. Sarcoidosis (Correct Answer)
- C. Lung cancer
- D. Histoplasmosis
- E. Silicosis
Asthma diagnosis and long-term management Explanation: ***Sarcoidosis*** - The presentation of progressive breathlessness and fatigue, coupled with **bilateral hilar lymphadenopathy (BHL)** on Chest X-ray and an **elevated serum ACE**, strongly indicates sarcoidosis. - The transbronchial biopsy showing **no caseating granulomas** is consistent with sarcoidosis, a disease characterized by **non-caseating granulomas**. *Tuberculosis* - Typically presents with **caseating granulomas** on biopsy, and hilar lymphadenopathy is often unilateral, unlike the patient's bilateral presentation. - Other common features include fever, night sweats, and weight loss, and **serum ACE** is not typically elevated. *Lung cancer* - While it can cause lymphadenopathy, it would typically show **malignant cells** on biopsy, not granulomas, and **elevated serum ACE** is not a diagnostic marker for lung cancer. - Clinical presentation often includes hemoptysis, unexplained weight loss, or persistent cough, which are not highlighted here. *Histoplasmosis* - This fungal infection can cause hilar lymphadenopathy and granulomas (often with subsequent calcification), but it is geographically endemic and **does not typically elevate serum ACE**. - Biopsy would reveal fungal organisms, which is not described in the patient's findings. *Silicosis* - An occupational lung disease due to **silica dust** exposure, which is not mentioned in the patient's history. - It typically causes upper lobe nodules and characteristic **eggshell calcification** of hilar lymph nodes, and **serum ACE** levels are usually normal.
Asthma diagnosis and long-term management UK Medical PG Question 7: A 54-year-old man presents with progressive dyspnea and bilateral lower lobe crackles. Chest X-ray shows bilateral infiltrates. He works in shipbuilding. What is the most likely diagnosis?
- A. COPD
- B. Asbestosis (Correct Answer)
- C. Silicosis
- D. Coal worker's pneumoconiosis
- E. Hypersensitivity pneumonitis
Asthma diagnosis and long-term management Explanation: ***Asbestosis***- The patient's history of working in **shipbuilding** is a classic exposure for **asbestos** fibers.- Asbestosis typically causes **interstitial pulmonary fibrosis**, preferentially affecting the **lower lobes**, leading to progressive dyspnea and **bibasilar crackles**. *COPD*- This involves **obstructive lung disease** (e.g., chronic bronchitis or emphysema) characterized by airflow limitation, not the restrictive pattern suggested by crackles and infiltrates.- CXR typically shows signs of **hyperinflation** or large bullae, rather than diffuse bilateral interstitial infiltrates.*Silicosis*- Silicosis is caused by inhaling **free crystalline silica** (e.g., mining, quarrying, sandblasting), an exposure typically unrelated to shipbuilding.- Radiographically, silicosis usually presents with **nodular opacities**, classically affecting the **upper lobes**.*Coal worker's pneumoconiosis*- This condition is due to the inhalation of **coal dust**, almost exclusively seen in **coal miners**.- Simple CWP generally causes small **nodular opacities**, also predominantly in the **upper lung fields**.*Hypersensitivity pneumonitis*- Caused by immunologic reactions to inhaled **organic antigens** (e.g., bird droppings, mold from farmers' lung), not asbestos exposure.- HP often presents with systemic symptoms, and the pathology involves the **alveolar walls** and terminal bronchioles, lacking the specific pleural/parenchymal changes linked to asbestos.
Asthma diagnosis and long-term management UK Medical PG Question 8: A 56-year-old man presents with progressive dyspnea and dry cough. HRCT shows honeycombing and traction bronchiectasis in lower lobes. He has clubbing. What is the most likely diagnosis?
- A. COPD
- B. Asthma
- C. Idiopathic pulmonary fibrosis (Correct Answer)
- D. Sarcoidosis
- E. Hypersensitivity pneumonitis
Asthma diagnosis and long-term management Explanation: ***Idiopathic pulmonary fibrosis***- The clinical presentation of **progressive dyspnea**, **dry cough**, and **clubbing** in an older patient, coupled with HRCT findings of **honeycombing** and **traction bronchiectasis** predominantly in the **lower lobes**, are classic features of **Usual Interstitial Pneumonia (UIP)** pattern, diagnostic of IPF.- **UIP** pattern on HRCT signifies extensive subpleural and basilar fibrosis with architectural distortion, where **honeycombing** represents clustered cystic airspaces and **traction bronchiectasis** indicates bronchial dilation due to surrounding fibrotic retraction.*COPD*- **COPD** is characterized by persistent **airflow limitation**, often with a history of smoking and a productive cough, contrasting with the dry cough and restrictive pattern of fibrosis seen here.- HRCT in COPD typically shows **emphysema** (centrilobular or panlobular) or **airway wall thickening**, but not the **honeycombing** and **traction bronchiectasis** indicative of severe pulmonary fibrosis.*Asthma*- **Asthma** is an inflammatory airway disease marked by **reversible airflow obstruction** and bronchial hyperresponsiveness, presenting with episodic wheezing, chest tightness, and dyspnea, which usually respond to bronchodilators.- HRCT in asthma may show **bronchial wall thickening** or **air trapping**, but it does not exhibit the progressive fibrotic changes like **honeycombing** or **traction bronchiectasis** seen in this patient.*Sarcoidosis*- **Sarcoidosis** is a multisystem granulomatous disease, often involving the lungs with **bilateral hilar lymphadenopathy** and a **perilymphatic distribution** of nodules, typically in the upper and mid lung zones.- While sarcoidosis can cause fibrosis (Stage 4), it typically manifests as **upper lobe predominant fibrosis** with conglomerate masses and volume loss, rather than the lower lobe predilection and characteristic UIP pattern.*Hypersensitivity pneumonitis*- Chronic **hypersensitivity pneumonitis (HP)** can lead to fibrosis, but HRCT often reveals a mosaic attenuation pattern, **centrilobular nodules**, and **air trapping**, with fibrosis potentially sparing the subpleural regions.- Although HP can mimic a UIP pattern in some cases, the classic presentation of progressive dyspnea, dry cough, clubbing, and strict lower lobe **honeycombing** and **traction bronchiectasis** points more strongly to IPF.
Asthma diagnosis and long-term management UK Medical PG Question 9: A 42-year-old man presents with progressive dyspnea and chest tightness. Spirometry shows FEV1 45% predicted, FEV1/FVC 0.85. HRCT shows lower lobe fibrosis. What is the most likely diagnosis?
- A. COPD
- B. Asthma
- C. Interstitial lung disease (Correct Answer)
- D. Bronchiectasis
- E. Pneumothorax
Asthma diagnosis and long-term management Explanation: ***Interstitial lung disease***- This pattern—low FEV1 (45% predicted) with a preserved FEV1/FVC ratio (0.85)—is characteristic of a **restrictive ventilatory defect**, where **lung volumes** are reduced due to stiff lungs.- The HRCT finding of **lower lobe fibrosis** directly confirms a restrictive pathology and is a hallmark of many Interstitial Lung Diseases (ILDs), such as **Idiopathic Pulmonary Fibrosis (IPF)**.*COPD*- COPD is an **obstructive lung disease** characterized by a **reduced FEV1/FVC ratio**, typically less than 0.70, which contradicts the given ratio of 0.85.- While it causes dyspnea, the primary HRCT findings are **emphysema** (centrilobular or panlobular) or **airway wall thickening**, not primarily lower lobe fibrosis.*Asthma*- Asthma is also an **obstructive lung disease** with variable and reversible airflow limitation, meaning the FEV1/FVC ratio would be **reduced**, often improving with bronchodilators.- HRCT findings in asthma might show **airway wall thickening** or **hyperinflation**, but it does not cause **pulmonary fibrosis**.*Bronchiectasis*- Bronchiectasis is characterized by permanent **dilation of the bronchi** and often presents with a chronic cough and sputum production.- Spirometry typically shows an **obstructive or mixed ventilatory defect**, not a purely restrictive pattern with a preserved FEV1/FVC ratio. HRCT shows **dilated airways** ("tram tracks" or "signet ring sign").*Pneumothorax*- A pneumothorax is the presence of **air in the pleural space**, causing acute dyspnea and chest pain, and resulting in a **collapsed lung** on imaging.- Spirometry would show severely reduced lung volumes, but the HRCT finding of **lower lobe fibrosis** is inconsistent with a pneumothorax, which is an acute air leak.
Asthma diagnosis and long-term management UK Medical PG Question 10: A 45-year-old man presents with progressive shortness of breath and fatigue. Chest X-ray shows bilateral hilar lymphadenopathy and pulmonary infiltrates. Serum ACE is elevated. Bronchoscopy with biopsy shows non-caseating granulomas. What is the most likely diagnosis?
- A. Tuberculosis
- B. Sarcoidosis (Correct Answer)
- C. Lung cancer
- D. Histoplasmosis
- E. Hypersensitivity pneumonitis
Asthma diagnosis and long-term management Explanation: ***Sarcoidosis***- The combination of **progressive shortness of breath** and **fatigue**, along with classic radiographic findings of **bilateral hilar lymphadenopathy** and pulmonary infiltrates, strongly suggests sarcoidosis.- The diagnosis is confirmed by the presence of **non-caseating granulomas** on biopsy and supported by an elevated **Angiotensin-Converting Enzyme (ACE)** level, which reflects granuloma burden.*Tuberculosis*- Tuberculosis typically presents with **caseating granulomas** (with central necrosis) on biopsy, not the non-caseating type seen in the patient.- Hilar adenopathy is often **unilateral** or accompanied by other findings like **apical infiltrates** or cavitations, rather than prominent bilateral hilar lymphadenopathy alone.*Lung cancer*- Lung cancer causes malignancy, and biopsy would reveal **atypical cells** and tumor architecture, not **non-caseating granulomas**.- While it can cause lymphadenopathy, **elevated ACE** is not a characteristic diagnostic feature.*Histoplasmosis*- This fungal infection can cause granulomas and hilar adenopathy, but the granulomas are often **caseating** or show evidence of fungal organisms upon special staining.- Diagnosis typically requires positive **fungal cultures** or serology, which are not described.*Hypersensitivity pneumonitis*- Although it can occasionally cause **non-caseating granulomas**, prominent **bilateral hilar lymphadenopathy** and **elevated serum ACE** are not typical primary features.- This condition is primarily an interstitial lung disease usually related to known environmental **antigen exposure**, which is not mentioned in the presentation.
More Asthma diagnosis and long-term management UK Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
